...
首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
【24h】

Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.

机译:子宫内造血细胞移植的单倍型改善了表型,并可以在犬白细胞粘附缺乏模型中诱导对产后同供体移植的耐受性。

获取原文
获取原文并翻译 | 示例
           

摘要

In the murine model, in utero hematopoietic cell transplantation (IUHCT) has been shown to achieve low levels of allogeneic chimerism and associated donor-specific tolerance permitting minimal conditioning postnatal hematopoietic stem cell transplantation (HSCT). In this pilot study, we investigated IUHCT in the canine leukocyte adhesion deficiency (CLAD) model. Haploidentical IUHCT resulted in stable low-level donor cell chimerism in all dogs that could be analyzed by sensitive detection methodology (4 of 10) through 18 months of follow-up. In the 2 CLAD recipients, low-level chimerism resulted in amelioration and complete reversal of the CLAD phenotype, respectively. Six recipients of IUHCT (5 carriers and 1 CLAD) subsequently received postnatal HSCT from the same haploidentical prenatal donor after minimal conditioning with busulfan 10 mg/kg. Chimerism in 2 of 5 CLAD carriers that underwent HSCT increased from < 1% pre-HSCT to sustained levels of 35% to 45%. Control animals undergoing postnatal haploidentical HSCT without IUHCT had no detectable donor chimerism. These results demonstrate that haploidentical IUHCT in the CLAD model can result in low-level donor chimerism that can prevent the lethal phenotype in CLAD dogs, and can result in donor-specific tolerance that can facilitate postnatal minimal conditioning HSCT.
机译:在鼠模型中,子宫内造血细胞移植(IUHCT)已显示达到低水平的异基因嵌合体和相关的供体特异性耐受性,从而使产后造血干细胞移植(HSCT)的适应性降至最低。在这项初步研究中,我们在犬白细胞粘附缺乏症(CLAD)模型中研究了IUHCT。单倍型IUHCT在所有狗中产生稳定的低水平供体细胞嵌合体,可以通过敏感的检测方法(10个中的4个)通过18个月的随访进行分析。在2位CLAD受体中,低水平的嵌合体分别导致CLAD表型的改善和完全逆转。六名IUHCT的接受者(5名携带者和1名CLAD)随后在以10mg / kg的白消安进行最低限度的调节后,从同一单身的产前供体接受了产后HSCT。在接受HSCT的5个CLAD携带者中,有2个的嵌合率从HSCT之前的<1%增加到35%到45%的持续水平。在没有IUHCT的情况下进行出生后单倍HSCT的对照动物没有可检测到的供体嵌合。这些结果表明,CLAD模型中的单倍型IUHCT可以导致低水平的供体嵌合,可以防止CLAD犬的致死表型,并可以导致供体特异性的耐受性,从而可以促进出生后的最低条件HSCT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号